Home›Ghaziabad›Oncquest Labs›Angiotensin Converting Enzyme

Angiotensin Converting Enzyme

~~₹1090~~₹763

30% Coupon

Oncquest Labs

4.1

NABL, CAP, ISO

ADD TO CART

Overview

Interpretations

FAQ's

Overview of Angiotensin Converting Enzyme

What is Angiotensin Converting Enzyme?

When you have granulomas that produce small bumps under the skin, a lingering cough, red watery eyes, and/or other symptoms suggestive of sarcoidosis; regularly when you have active sarcoidosis to monitor its course.

Sample Type

The sample type collected for Angiotensin Converting Enzyme is: Blood

Preparation for Angiotensin Converting Enzyme

No special preparation required

Why Get Tested for Angiotensin Converting Enzyme?

If you have signs or symptoms suggestive of sarcoidosis like chronic cough or shortness of breath, watery eyes, joint pains or grnaolaomas
If you have been already diagnosed with sarcoidosis, this test may be ordered routinely to monitor the disease activity

What Results of Angiotensin Converting Enzyme mean?

Interpretations

An increased ACE level in a person with clinical findings suggestive of sarcoidosis means that it is likely that a person has an active case of sarcoidosis, if other diseases have been ruled out. The finding of a high ACE level helps to confirm the diagnosis
A normal ACE level cannot be sued to rule out sarcoidosis since sarcoidosis may be present without an elevated ACE level
It may also be used to monitor the course of treatment in sarcoidosis. An initial high level which decreases over time usually indicates spontaneous or therapy induced remission and a favorable prognosis. On the other hand, a rising ACE level may indicate either the disease is not responding or it is progressing

Patient Concerns about Angiotensin Converting Enzyme

Frequently Asked Questions about Angiotensin Converting Enzyme

Q. Are there any other conditions except sarcoidosis which can lead to increased or decreased ACE levels?

Decreased ACE levels may also be seen in lung diseases like emphysema, hypothyroidism, starvation, steroid therapy. The levels may be moderately increased in hyperthyroidism, diabetes, alcoholic cirrhosis, lymphoma, tuberculosis, leprosy

Provided By

Oncquest Labs

4.1

NABL

CAP

ISO

With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.